Results overview: Found 6 records in 0.02 seconds.
Articles, 5 records found
Research literature, 1 records found
Articles 5 records found  
1.
12 p, 1.3 MB Sex-Related Differences in Patients With Unexplained Syncope and Bundle Branch Block : Lower Risk of AV Block and Lesser Need for Cardiac Pacing in Women / Francisco-Pascual, Jaume (Universitat Autònoma de Barcelona. Departament de Medicina) ; Rivas-Gándara, Nuria (Universitat Autònoma de Barcelona. Departament de Medicina) ; Bach-Oller, Montserrat (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Badia-Molins, Clara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Maymi-Ballesteros, Manel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Benito, Begoña (Universitat Autònoma de Barcelona. Departament de Medicina) ; Pérez-Rodón, Jordi (Universitat Autònoma de Barcelona. Departament de Medicina) ; Santos-Ortega, Alba (Universitat Autònoma de Barcelona. Departament de Medicina) ; Sambola-Ayala, Antonia (Universitat Autònoma de Barcelona. Departament de Medicina) ; Roca-Luque, Ivo (Hospital Clínic i Provincial de Barcelona) ; Cantalapiedra, Javier (Universitat Autònoma de Barcelona. Departament de Medicina) ; Rodríguez-Silva, Jesús (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pascual-González, Gabriel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Moya Mitjans, Àngel (Cardiology Department, Hospital Universitari Dexeus) ; Ferreira-Gonzalez, Ignacio (Universitat Autònoma de Barcelona. Departament de Medicina)
To analyze if there are sex-related differences in patients with unexplained syncope and bundle branch block (BBB). Despite increasing awareness that sex is a major determinant of the incidence, etiology, and the outcomes of different arrhythmias, no studies have examined differences in presentation and outcomes between men and women with syncope and BBB. [...]
2022 - 10.3389/fcvm.2022.838473
Frontiers in Cardiovascular Medicine, Vol. 9 (february 2022)  
2.
11 p, 2.8 MB Management of Heart Failure with Reduced Ejection Fraction after ESC 2016 Heart Failure Guidelines : The Linx Registry / De Frutos, Fernando (Hospital Universitari de Bellvitge) ; Mirabet Pérez, Sonia (Institut d'Investigació Biomèdica Sant Pau) ; Ortega-Paz, Luis (Hospital Clínic i Provincial de Barcelona) ; Buera Surribas, Irene (Hospital de Viladecans) ; Darnés, Sara (Hospital de Figueres) ; Farré, Núria (Institut Hospital del Mar d'Investigacions Mèdiques) ; Perez, Bernardo (Hospital General de Granollers) ; Adeliño, Raquel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Bascompte, Ramón (Hospital Arnau de Vilanova (Lleida, Catalunya)) ; Pérez-Rodón, Jordi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Aparicio, Xavier (Hospital de Mataró. Consorci Sanitari del Maresme) ; Sutil-Vega, Mario (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Soto, Adriana (Hospital de Martorell) ; Faraudo, Mercedes (Hospital de Sant Joan Despí Moisès Broggi) ; Cainzos-Achirica, Miguel (Hospital Universitari de Bellvitge) ; Manito, Nicolás (Hospital Universitari de Bellvitge) ; Universitat Autònoma de Barcelona
In May 2016, a new version of the European Society of Cardiology (ESC) Guidelines for the management of heart failure (HF) was released. The aim of this study was to describe the management of HF with reduced ejection fraction after the publication of ESC Guidelines. [...]
2020 - 10.1002/ehf2.12567
ESC Heart Failure, Vol. 7 (january 2020) , p. 25-35  
3.
5 p, 5.1 MB Life-threatening and life-saving inappropriate implantable cardioverter defibrillator shocks / Pérez Rodon, Jordi (Universitat Autònoma de Barcelona) ; Doiny, David (Universitat Autònoma de Barcelona) ; Miranda, Berta (Universitat Autònoma de Barcelona) ; Rivas Gándara, Nuria (Universitat Autònoma de Barcelona) ; Roca Luque, Ivo (Universitat Autònoma de Barcelona) ; Francisco Pascual, Jaume (Universitat Autònoma de Barcelona) ; Lidón, Rosa Maria (Universitat Autònoma de Barcelona) ; García-Dorado, David (Universitat Autònoma de Barcelona) ; Moya Mitjans, Àngel (Universitat Autònoma de Barcelona)
An implantable cardioverter defibrillator (ICD) lead dislodgement into the right atrium is a dangerous situation, particularly in patients in atrial fibrillation because atrial fibrillation can be sensed as ventricular fibrillation and true ventricular fibrillation induced with an inappropriate shock. [...]
2017 - 10.1002/ccr3.893
Clinical Case Reports, Vol. 5, Issue 4 (April 2017) , p. 521-525  
4.
10 p, 426.6 KB A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies / Spreafico, A. (University of Toronto. Princess Margaret Cancer Centre. Division of Medical Oncology and Hematology (Canada)) ; Delord, Jean-Pierre (Institut Claudius Regaud (France)) ; Mattos Arruda, Leticia de (Hospital Universitari Vall d'Hebron) ; Berge, Y. (Institut Claudius Regaud (France)) ; Pérez Rodon, Jordi (Hospital Universitari Vall d'Hebron) ; Cottura, E. (Institut Claudius Regaud (France)) ; Bedard, Philippe L (University of Toronto. Princess Margaret Cancer Centre. Division of Medical Oncology and Hematology (Canada)) ; Akimov, Mikhail (Novartis Pharma AG (Switzerland)) ; Lu, H. (Novartis Pharmaceuticals Corp (USA)) ; Pain, S. (Novartis Pharmaceuticals Corp (USA)) ; Kaag, A. (Novartis Pharma AG (Switzerland)) ; Siu, L. L. (University of Toronto. Princess Margaret Cancer Centre. Division of Medical Oncology and Hematology (Canada)) ; Cortés, Javier (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Heat-shock protein 990 (HSP990) is a potent and selective synthetic small-molecule HSP90 inhibitor. The primary objectives of this phase I first-in-human study were to determine dose-limiting toxicities (DLTs), maximum-tolerated dose (MTD) and recommended phase II dose (RP2D). [...]
2015 - 10.1038/bjc.2014.653
British Journal of Cancer, Vol. 112 (February 2015) , p. 650-659  
5.
21 p, 3.3 MB Single Intracoronary Injection of Encapsulated Antagomir-92a Promotes Angiogenesis and Prevents Adverse Infarct Remodeling / Bellera Gotarda, Neus (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Barba, Ignasi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rodriguez-Sinovas, Antonio (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ferret, Eulalia (I+D Pierre-Fabre Ibérica S.A) ; Asín, Miguel Angel (I+D Pierre-Fabre Ibérica S.A) ; Gonzalez-Alujas, MªTeresa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pérez-Rodón, Jordi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Esteves, Marielle (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Fonseca, Carla (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Toran, Nuria (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; García del Blanco, Bruno (Hospital Universitari Vall d'Hebron) ; Pérez, Amadeo (I+D Pierre-Fabre Ibérica S.A) ; García-Dorado, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Small and large preclinical animal models have shown that antagomir-92a-based therapy reduces early postischemic loss of function, but its effect on postinfarction remodeling is not known. In addition, the reported remote miR-92a inhibition in noncardiac organs prevents the translation of nonvectorized miR-targeted therapy to the clinical setting. [...]
2014 - 10.1161/JAHA.114.000946
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 3 (september 2014)  

Research literature 1 records found  
1.
201 p, 1.8 MB Optimización del tratamiento farmacológico en pacientes con disfunción sistólica severa del ventrículo izquierdo en una unidad de insuficiencia cardiaca: implicaciones en la indicación de un desfibrilador automático implantable en prevención primaria y factores predictores de ausencia de remodelado reverso del ventrículo izquierdo / Pérez Rodon, Jordi ; Galve Basilio, Enrique, dir. ; Moya Mitjans, Àngel, dir. ; García Dorado, D., dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
[Barcelona] : Universitat Autònoma de Barcelona, 2016  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.